Disease Studies

One Nucleus – BioWednesday Webinar – Feb 3, 2021

Oxford, UK – PrecisionLife CEO Dr Steve Gardner will be chairing a discussion at this event, organised by One Nucleus in collaboration with Stevenage Bioscience Catalyst.

The session will feature a panel of experienced entrepreneurs discussing the different ways that AI can be used to aid successful drug discovery and development, what is needed to optimize these various business models and ultimately how can companies mature innovation in this space to create patient impact faster.

For more information please see https://onenucleus.com/civicrm/event/info?reset=1&id=1423


More News & Media

View All News & Media

BIA Bioscience Forum

London, 14 October 2021 PrecisionLife CEO, Dr Steve Gardner, will join an expert panel to discuss access to NHS…

24/09/21
Read more

Neuropsychiatric Drug Development Summit

Online, 29-30 September 2021 Members of the PrecisionLife team will join leaders from the likes of Sunovion, Merck, Takeda,…

24/09/21
Read more

Bio Digital 2021

10-11 June 2021 Accelerating a BIO-Revolution through global partnerships, collaboration, and thought leadership We are joining the the world’s…

28/04/21
Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.

Contact us

If you have any questions or would like to speak to us in terms of potential collaborations or partnership opportunities, please get in touch using the form below or email info@precisionlife.com and we will get back to you as soon as we can. Note that our Privacy Policy and Terms & Conditions apply.


UK

Unit 8b Bankside
Hanborough Business Park
Long Hanborough, OX29 8LJ

USA

1 Broadway Fl 14
Cambridge
MA 02142-1187

Denmark

Agern Allé 3
DK-2970
Hørsholm

Poland

CIC Ul
Chmielna 73m
00-801 Warszawa